Bristol Myers Squibb Narrows Full-Year Earnings Guidance
October 27 2021 - 07:51AM
Dow Jones News
By Matt Grossman
Bristol Myers Squibb Co. on Wednesday narrowed the range of its
full-year adjusted-earnings guidance.
The New York City-based pharmaceutical company said it now
expects adjusted earnings of $7.40 a share to $7.55 a share.
Previously, it forecasted adjusted earnings of $7.35 a share to
$7.55 a share.
The guidance assumes world-wide revenue growth in the high
single digits, Bristol said.
Marketing, selling and administrative expenses will be in line
with 2020 levels, while research and development expenses is likely
to increase by a low-single-digits percentage, the company
estimated.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
October 27, 2021 07:36 ET (11:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2023 to Mar 2024